drugset / Trial / NCT00418730

Efficacy Study of Topical NEOSH101 to Treat Male Pattern Hair Loss

NCT00418730 ↗

Phase 2 Completed 180 enrolled Neosil, Inc.
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to measure the hair growth response to topical NEOSH101 when applied twice daily to the balding scalp for 16 weeks. One hundred eighty men with Norwood/Hamilton grades III-IV with thinning in the top and center of the scalp will participate. Three equally sized treatment groups (60 men each) will receive either topical NEOSH101 2.0%, minoxidil 5%, or placebo.

Timeline

Start
2007-01
Primary completion
2007-10
Completion
2008-04

Drugs

EvaluationDrugModalityDoseRoute
Subject NEOSH101 Peptide 2 % Topical

Indications